[Current status of therapy of leprosy].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D006801:Humans; D007918:Leprosy / Q000628:therapy*; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D013882:Thiosemicarbazones; D000077145:Sulfanilamide; D010131:Aminosalicylic Acid; D000324:Adrenocorticotropic Hormone
ACTH/therapeutic use; ANTIBIOTICS/therapeutic use; LEPROSY/therapy; PARA-AMINOSALICYLIC ACID/therapeutic use; SULFONAMIDES/therapeutic use; THIOSEMICARBAZONES/therapeutic use
Etat actuel du traitement de la lepre.